<DOC>
	<DOCNO>NCT02931526</DOCNO>
	<brief_summary>The aim study determine Pharmacokinetics/Pharmacodynamics ( PK/PD ) tigecycline critical ill patient undergo continuous renal replacement therapy（CRRT）and examine whether dosage need adjustment . The study observe two group patient respectively compare difference . Patients need receive CRRT treat high-dose tigecycline collect Group CRRT . Patients treat high-dose tigecycline collect Group non-CRRT .</brief_summary>
	<brief_title>Study Tigecycline Pharmacokinetics Patients Undergoing Continuous Renal Replacement Therapy ( CRRT )</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Aged 1875 year , hospitalize ICU patient , male female ; definitive diagnosis treat tigecycline bacterial infection ; receive CRRT renal insufficiency receive CRRT normal renal function . Patients ChildPugh C cirrhosis ; Allergic tetracycline tigecycline ; Patients receive CRRT &lt; 3 day treat tigecycline &lt; 3 day ; Patients pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Tigecycline</keyword>
	<keyword>Continuous Renal Replacement Therapy</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>